Scientari is building an ecosystem of strategy guides, interactive analysis tools, and decision systems for biotech and pharma professionals.
Clinical Trial Protocol Optimization
Most Phase 2 failures aren’t drug failures — they’re design failures. TrialReadiness scores a protocol’s measurement architecture on a 0–40 scale before the first patient is enrolled, surfacing where timing and assessment density could bury a real signal. Grounded in a retrospective analysis of 275,000 trials. Most recommendations re-allocate samples you’re already collecting rather than adding patient visits.
Drug Repositioning Intelligence
Repositioning drives roughly 30% of FDA approvals, but a single BD&L evaluation still burns 200+ analyst hours and up to $75K in consultant fees — often without a clear answer. Scientari’s Repothesis™ platform scores every compound–indication pair on scientific evidence and commercial viability independently, delivering a board-ready repositioning call at a fraction of the time and cost.
Strategic Partnerships
We identify high-value partnerships to fuel your company’s growth. Our deep understanding of bioinformatics, genomics, digital health and high-performance computing enables us to connect you with the right partners to achieve strategic objectives.
Bio+AI Blog and Data Resources
Stay ahead of the curve with fresh news & insights on AI for drug discovery / repurposing, clinical optimization and conversational interfaces.. Our Data Resources also keep pace with rapidly evolving data sources for machine learning.
Find out how TrialReadiness can help you optimize clinical trial protocols before heavy Phase 2 expenses begin. To schedule a 1:1 meeting in San Diego during BIO2026, contact Scientari today chris@scientari.com
